搜尋結果
現行免疫療法搭配癌症個人化疫苗,治療肝癌效果加倍
科技新報 TechNews· 5 日前肝癌是全球癌症死因的第三位,每年約 80 萬人死於肝癌。雖然醫學進步,已有標靶藥物及免疫療法用於治療晚期肝癌患者,但療效仍十分有限。最近 Geneos ...
The Devil Lost In Details: Tasmanian Devil Cancer Transmission Is NOT Slowing
Forbes· 4 日前Three scientists and veterinarians based at the University of Cambridge report new evidence that contradicts results published ...
ImmunityBio Announces FDA Approval of ANKTIVA®, First-in-Class IL-15 Receptor Agonist for ...
Bastillepost· 2 日前ImmunityBio, Inc. ( NASDAQ: IBRX ), an immunotherapy company, today announced that the U.S. ...
InnovationRx: Chelsea Clinton Invests In 24/7 Pediatrics Startup
Forbes· 23 小時前The U.S. healthcare system is not set up to take care of a kid with a rash or a fever at 2 a.m. ...
Gene Therapy: Non-Viral Vectors
Forbes· 7 日前This story is part of a series on the current progression in Regenerative Medicine. In 1999, I ...
Chinese scientists use AI algorithm to better predict unknown tumor origins
China Daily· 6 日前A team of Chinese scientists have designed an artificial intelligence (AI) tool that predicts hard-to-identify ...
Former NIH Director Francis Collins Has Prostate Cancer. Use His Story To Reduce Your Risk Of ...
Forbes· 6 日前Dr. Francis Collins revealed that he has prostate cancer, and that it recently transformed into ...
Clean Away: An Earth Day Essay And Thank You From Artist Sage Bava
Forbes· 3 日前The relationship between music and nature is a long and storied one. From Neil Young’s ...
Final farewell to Hong Kong girl Chau Tin-yu who died in vegetative state
South China Morning Post· 5 日前Chau said that he still had not heard from the Hospital Authority or Queen Mary Hospital, and ...
U.S. FDA approves ImmunityBio's bladder cancer therapy
Reuters· 2 日前, opens new tab combination therapy to treat a type of bladder cancer, marking an end to the ...